Innovative Tools and Strategies for Metabolomics Data Analysis [PDF]
La metabolòmica és un bon enfocament per comprendre els fenotips. Això és valuós en aplicacions biomèdiques, ja que els metabòlits proporcionen informació sobre els processos bioquímics en temps real.
Llambrich Rodriguez, Maria
core
Développement d'outils computationnels pour une approche de métabolomique non ciblée par spectrométrie de masse à haut débit [PDF]
La métabolomique est l'étude des petites molécules produites par un système biologique. L'objectif principal des études en métabolomique non ciblées est la recherche d'une signature moléculaire, à base de biomarqueurs, permettant de distinguer deux ...
Plante, Pier-Luc, Plante, Pier-Luc
core +1 more source
Asenapine add-on treatment for schizophrenia adults who received antipsychotics: A 52-week, open-label study. [PDF]
Kishi T +5 more
europepmc +1 more source
Amurensin G Sensitized Cholangiocarcinoma to the Anti-Cancer Effect of Gemcitabine via the Downregulation of Cancer Stem-like Properties. [PDF]
Na YJ, Lee HK, Choi KC.
europepmc +1 more source
Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine. [PDF]
Takao N, Murai T, Fujiwara H.
europepmc +1 more source
Participation in physical activity decreased more in people with rheumatoid arthritis than the general population during the COVID-19 lockdown: a cross-sectional study. [PDF]
Balchin C +4 more
europepmc +1 more source
Continuation rate for asenapine and brexpiprazole treatment in patients with schizophrenia. [PDF]
Inoue Y +6 more
europepmc +1 more source
Chronic antipsychotic treatment exerts limited effects on the mania-like behavior of dopamine transporter knockdown mice. [PDF]
Cope ZA +9 more
europepmc +1 more source
Asenapine-induced severe dystonia in a patient with schizophrenia: medication error due to sound-alike drug. [PDF]
Wulff S +3 more
europepmc +1 more source
The "specific" P-glycoprotein inhibitor zosuquidar (LY335979) also weakly inhibits human organic cation transporters. [PDF]
Bajraktari-Sylejmani G +4 more
europepmc +1 more source

